Sanofi India Limited
Sanofi India Limited, a subsidiary of the global healthcare leader Sanofi, is headquartered in Mumbai, India. Established in 1956, the company has made significant strides in the pharmaceutical industry, focusing on areas such as diabetes, cardiovascular health, and vaccines. With a strong presence across major operational regions in India, Sanofi India is committed to improving patient outcomes through innovative healthcare solutions. The company offers a diverse portfolio of core products, including insulin therapies and specialty medicines, which are distinguished by their quality and efficacy. Sanofi India has achieved notable market recognition, consistently ranking among the top pharmaceutical companies in the country. With a dedication to research and development, Sanofi India continues to advance healthcare, making a meaningful impact on the lives of patients across the nation.
DitchCarbon Score
How does Sanofi India Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi India Limited's score of 59 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi India Limited's reported carbon emissions
In 2023, Sanofi India Limited reported total carbon emissions of approximately 8,963,400 kg CO2e. This figure includes about 486,630 kg CO2e from Scope 1 emissions and approximately 8,476,770 kg CO2e from Scope 2 emissions. Compared to 2022, where total emissions were about 9,766,800 kg CO2e, the company achieved a reduction of approximately 803,400 kg CO2e. Over the past few years, Sanofi India has demonstrated a commitment to reducing its carbon footprint. In 2022, the company recorded total emissions of about 9,766,800 kg CO2e, which included approximately 484,010 kg CO2e from Scope 1 and about 9,282,790 kg CO2e from Scope 2. In 2021, emissions were higher at approximately 10,852,240 kg CO2e, indicating a positive trend in emission reductions. Despite the absence of specific reduction targets or initiatives disclosed, Sanofi India continues to focus on managing its carbon emissions effectively. The company’s efforts align with broader industry standards for climate action, reflecting a commitment to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 403,690 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 10,663,820 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi India Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
